The use of lipoteichoic acid (LTA) from Streptococcus pyogenes to induce a serum factor causing tumour necrosis.
D000818:Animals; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D005260:Female; D005354:Fibrosarcoma / Q000188:drug therapy; D006023:Glycoproteins / Q000096:biosynthesis* / Q000627:therapeutic use; D006131:Growth Inhibitors / Q000096:biosynthesis* / Q000627:therapeutic use; D008070:Lipopolysaccharides; D051379:Mice; D008807:Mice, Inbred BALB C; D008813:Mice, Inbred ICR; D010712:Phosphatidic Acids / Q000494:pharmacology*; D013297:Streptococcus pyogenes; D013682:Teichoic Acids / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha
D006023:Glycoproteins; D006131:Growth Inhibitors; D008070:Lipopolysaccharides; D010712:Phosphatidic Acids; D013682:Teichoic Acids; D014409:Tumor Necrosis Factor-alpha; C009900:lipoteichoic acid